 CAMBRIDGE, Mass., March 24, 2021 GLOBE NEWSWIRE -- Praxis Precision Medicines, Inc. NASDAQ: PRAX, a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders CNS characterized by neuronal imbalance, today announced that management will participate in a fireside chat at Stifels 3rd Annual CNS Day on Wednesday, March 31, 2021 at 8:30 a.m. ET. 